Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40165 | ISIN: US64051A1016 | Ticker-Symbol:
NASDAQ
05.06.25 | 21:53
7,480 US-Dollar
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
NEONC TECHNOLOGIES HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
NEONC TECHNOLOGIES HOLDINGS INC 5-Tage-Chart

Aktuelle News zur NEONC TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15:30NeOnc Technologies appoints new chief clinical officer1
15:22NeOnc Technologies ernennt neuen Chief Clinical Officer2
15:06NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs1
DiNEONC TECHNOLOGIES HOLDINGS, INC. - 8-K, Current Report1
09.05.NEONC TECHNOLOGIES HOLDINGS, INC. - 10-Q, Quarterly Report1
29.04.NEONC TECHNOLOGIES HOLDINGS, INC. - S-1, General form for registration of securities-
NEONC TECHNOLOGIES Aktie jetzt für 0€ handeln
15.04.NeOnc Technologies Holdings, Inc.: NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets1
14.04.NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September157-- Trial Read-Out Data Expected in Early 2026 -- CALABASAS, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company...
► Artikel lesen
10.04.NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company's New President1
08.04.NeOnc Technologies Holdings, Inc.: NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy90CALABASAS, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous...
► Artikel lesen
31.03.NeOnc Falls Despite FDA Nod-
31.03.NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas2
27.03.NEONC TECHNOLOGIES HOLDINGS, INC. - 8-K, Current Report1
27.03.NeOnc Technologies Holdings, Inc.: NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments108WESTLAKE VILLAGE, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq Global Market: NTHI), a clinical-stage medical biotechnology company, today announced a strategic...
► Artikel lesen
26.03.Biotech NeOnc Technologies' share registration declared effective ahead of Nasdaq direct listing2
25.03.NEONC TECHNOLOGIES HOLDINGS, INC. - S-8, Securities to be offered to employees in employee benefit plans1
25.03.NeOnc Technologies Holdings, Inc.: NeOnc Technologies Holdings Announces Effectiveness of Registration Statement and Anticipated Listing Date of Common Stock on Nasdaq Global Market115WESTLAKE VILLAGE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. ("NeOnc" or the "Company," to be listed on the NASDAQ Global Market under the symbol: NTHI), a clinical-stage...
► Artikel lesen
25.03.NEONC Technologies Holdings, Inc. Appoints Dr. Alan Chiang to its Board of Directors1
25.03.NeOnc Technologies Holdings, Inc.: NeOnc Technologies Appointments the Honorable Jimmy Delshad to its Board of Directors1
25.03.NEONC Technologies Holdings, Inc. Appoints Renowned Neurosurgeon Dr. Steven L. Giannotta to its Board of Directors1
Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1